Literature DB >> 32031541

Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection.

Robert Flisiak1, Dorota Zarębska-Michaluk2, Jerzy Jaroszewicz3, Beata Lorenc4, Jakub Klapaczyński5, Magdalena Tudrujek-Zdunek6, Marek Sitko7, Włodzimierz Mazur8, Ewa Janczewska9, Paweł Pabjan2, Dorota Dybowska10, Iwona Buczyńska11, Agnieszka Czauż-Andrzejuk12, Teresa Belica-Wdowik13, Hanna Berak14, Rafał Krygier15, Maciej Piasecki3, Beata Dobracka16, Jolanta Citko17, Anna Piekarska18, Łukasz Socha19, Zbigniew Deroń20, Olga Tronina21, Łukasz Laurans22, Jolanta Białkowska23, Krzysztof Tomasiewicz6, Waldemar Halota10, Krzysztof Simon11, Małgorzata Pawłowska10.   

Abstract

Entities:  

Year:  2020        PMID: 32031541     DOI: 10.20452/pamw.15181

Source DB:  PubMed          Journal:  Pol Arch Intern Med        ISSN: 0032-3772


× No keyword cloud information.
  5 in total

1.  Significant Decrease in the Prevalence of Anxiety and Depression after Hepatitis C Eradication.

Authors:  Justyna Slonka; Damian Piotrowski; Ewa Janczewska; Arkadiusz Pisula; Joanna Musialik; Jerzy Jaroszewicz
Journal:  J Clin Med       Date:  2022-05-28       Impact factor: 4.964

2.  Searching for the optimal population for hepatitis C virus screening in Poland.

Authors:  Anna Piekarska; Krzysztof Tomasiewicz; Waldemar Halota; Jerzy Jaroszewicz; Rafał Krygier; Piotr Małkowski; Małgorzata Pawłowska; Krzysztof Simon; Olga Tronina; Dorota Zarębska-Michaluk; Robert Flisiak
Journal:  Clin Exp Hepatol       Date:  2020-04-30

3.  Real-world direct-acting antiviral treatment in kidney transplant and hemodialysis patients: the EpiTer-2 multicenter observational study.

Authors:  Olga Tronina; Magdalena Durlik; Iwona Orłowska; Beata Lorenc; Tadeusz W Łapiński; Aleksander Garlicki; Dorota Dybowska; Dorota Zarębska-Michaluk; Magdalena Tudrujek-Zdunek; Jolanta Citko; Ewa Janczewska; Marcin Kaczmarczyk; Jerzy Jaroszewicz; Rafał Krygier; Jakub Klapaczyński; Beata Dobracka; Jolanta Białkowska-Warzecha; Anna Piekarska; Krzysztof Simon; Waldemar Halota; Małgorzata Pawłowska; Krzysztof Tomasiewicz; Robert Flisiak
Journal:  Ann Gastroenterol       Date:  2021-02-05

Review 4.  Genotype 3-hepatitis C virus' last line of defense.

Authors:  Dorota Zarębska-Michaluk
Journal:  World J Gastroenterol       Date:  2021-03-21       Impact factor: 5.742

Review 5.  HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons.

Authors:  Robert Flisiak; Dorota Zarębska-Michaluk; Egle Ciupkeviciene; Sylvia Drazilova; Sona Frankova; Ivica Grgurevic; Bela Hunyady; Peter Jarcuska; Limas Kupčinskas; Michael Makara; Gunita Saulite-Vanaga; Marieta Simonova; Jan Sperl; Ieva Tolmane; Adriana Vince
Journal:  Viruses       Date:  2022-02-26       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.